During pregnancy, a woman’s body goes through major changes in how it handles calcium and bone health. Scientists wanted to understand why some women’s bones break down more than others during this time. They studied 575 Mexican women and looked at specific genes related to vitamin D and estrogen—two things that affect bone strength. They found that women with a certain version of the vitamin D receptor gene had about 24% less bone breakdown during pregnancy and after birth. This discovery suggests that your genes play a role in how well your bones handle the stress of pregnancy, which could help doctors better understand who might need extra bone support.
The Quick Take
- What they studied: Whether specific genes that control vitamin D and estrogen affect how much bone breaks down in pregnant women and new mothers
- Who participated: 575 pregnant women from Mexico who were part of a larger health study tracking environmental exposures. Researchers measured their bone breakdown at different points during pregnancy and one month after birth.
- Key finding: Women who carried a specific version of the vitamin D receptor gene (called the CC genotype at rs731236) had about 24% less bone breakdown compared to other women. This was a statistically significant finding (p = 0.005), meaning it’s unlikely to be due to chance.
- What it means for you: Your genes may influence how much your bones break down during pregnancy. If you have this protective gene variant, your bones may naturally handle pregnancy stress better. However, this is one study, and more research is needed before doctors can use this information to predict individual bone loss or recommend personalized treatments.
The Research Details
Researchers followed 575 pregnant women from Mexico and measured a substance in their urine called NTx, which indicates how much bone is breaking down. They collected these measurements during each trimester of pregnancy and again one month after birth. They also identified six specific genetic variations in two genes: the estrogen receptor gene (ESR1) and the vitamin D receptor gene (VDR). These genes were chosen because they’re known to affect how bones respond to hormones and vitamin D. The researchers used statistical methods to see if women with different gene versions had different amounts of bone breakdown, while accounting for other factors like age, diet, calcium intake, and whether they were breastfeeding.
Understanding which genes affect bone loss during pregnancy is important because pregnancy naturally causes bone breakdown as the body adjusts to new demands. Some women lose more bone than others, and this could affect their long-term bone health. By identifying genetic factors, scientists can better understand why this happens and potentially help women at higher risk of bone problems.
This study has several strengths: it included a large number of women (575), measured bone breakdown at multiple time points throughout pregnancy, and adjusted for many factors that could affect results. However, the study only included Mexican women, so results may not apply equally to other populations. The researchers only found one significant genetic association out of six they tested, which suggests the effect of genes on bone loss during pregnancy may be modest or that other factors are also important.
What the Results Show
The main finding was that women with the CC version of the vitamin D receptor gene (specifically at the location called rs731236) had significantly lower bone breakdown markers—about 24% lower than women with other gene versions. This protective effect was statistically significant (p = 0.005), meaning researchers are confident this wasn’t due to random chance. The other five genetic variations tested (three in the estrogen receptor gene and two other vitamin D receptor variations) did not show significant associations with bone breakdown. This suggests that while vitamin D receptor genetics may play a role in pregnancy-related bone loss, the effect is specific to certain genetic variations and not all genes involved in bone health have equal importance.
The study adjusted for several other factors known to affect bone health during pregnancy, including maternal age, whether it was the woman’s first pregnancy, blood iron levels (hematocrit), calcium intake, total energy intake, and breastfeeding status. The researchers used advanced statistical methods that could detect patterns across the entire pregnancy period and postpartum month, rather than just looking at single time points. This comprehensive approach strengthens confidence in the main finding about the vitamin D receptor gene.
Previous research has shown that pregnancy causes significant bone loss, particularly in the spine and hip, and that this loss is usually recovered after pregnancy ends. Some studies have suggested that genetic factors influence how much bone loss occurs, but evidence specifically linking vitamin D receptor genes to pregnancy-related bone loss has been limited. This study adds to that evidence by identifying a specific genetic variant that appears protective. However, the finding is relatively modest in size and needs confirmation in other populations before it changes clinical practice.
The study only included women from Mexico, so the findings may not apply equally to women of other ethnic backgrounds, as genetic effects can vary between populations. The researchers tested six genetic variations, and only one showed a significant effect—this means there’s a small possibility that this finding could be due to chance, though the statistical test suggests otherwise. The study measured bone breakdown through urine tests rather than bone density scans, which is a good indicator but not the same as measuring actual bone loss. Additionally, the study couldn’t determine whether the protective effect of this gene variant continues long-term or whether it affects actual bone fracture risk.
The Bottom Line
If you’re pregnant or planning pregnancy, this research suggests that genetic factors may influence how your bones respond to pregnancy. However, this is one study, and current evidence doesn’t support genetic testing for this specific variant as a routine clinical tool. Instead, focus on proven bone-health strategies: ensure adequate calcium intake (1000 mg daily for most adults), get enough vitamin D (600-800 IU daily), engage in weight-bearing exercise as approved by your doctor, and discuss bone health with your healthcare provider, especially if you have risk factors for bone loss.
This research is most relevant to pregnant women, women planning pregnancy, and healthcare providers caring for pregnant patients. It’s particularly interesting for women with family histories of osteoporosis or bone problems, though genetic testing isn’t yet recommended based on this single study. Women of Mexican descent may find this especially relevant since the study was conducted in that population. This research is less immediately applicable to non-pregnant individuals, though it contributes to our general understanding of bone health.
Bone loss during pregnancy typically occurs gradually throughout pregnancy and the early postpartum period. Most women recover their bone density within 12-24 months after pregnancy ends, especially if they breastfeed and maintain good nutrition. If you have concerns about bone loss, improvements from dietary changes and exercise typically take several months to show measurable effects.
Want to Apply This Research?
- Track daily calcium and vitamin D intake (target: 1000 mg calcium, 600-800 IU vitamin D) and weight-bearing exercise minutes during pregnancy and postpartum. Note any bone-related symptoms like joint pain or unusual fatigue to discuss with your healthcare provider.
- Use the app to set daily reminders for calcium-rich foods (dairy, leafy greens, fortified products) and vitamin D sources (fatty fish, egg yolks, fortified milk). Log prenatal vitamin intake and any exercise approved by your doctor to ensure you’re meeting bone-health targets during pregnancy.
- Create a long-term tracking dashboard that monitors calcium and vitamin D intake across trimesters and the postpartum year. Set quarterly check-in reminders to review trends and adjust nutrition if needed. Share summaries with your healthcare provider at prenatal visits to ensure adequate bone-supporting nutrition throughout pregnancy and recovery.
This research describes associations between specific genes and bone breakdown during pregnancy in one population. It does not establish that genetic testing should be used to predict individual bone loss or guide treatment decisions. Pregnant women should discuss bone health, calcium intake, vitamin D supplementation, and exercise with their healthcare provider. This information is educational and should not replace professional medical advice. If you have concerns about bone health during pregnancy or postpartum, consult with your obstetrician or healthcare provider.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.